Our mission is to deliver safe, innovative cardiovascular medical devices that empower doctors and enhance patient care worldwide. We’re dedicated to advancing vascular interventional treatment solutions for lasting clinical benefits and improved quality of life for patients everywhere.
The Iron-Based Bioresorbable Scaffold(IBS) uses iron as the matrix. Through a high-purity nitriding process, the iron-based scaffold has the same mechanical properties as the permanent cobalt-chromium alloy stent, providing a safe and non-toxic solution.
High-purity nitrided iron matrix offer exceptional mechanical strength, providing reliable and extended support for blood vessels. Unlike current BRSs, the matrix ensure durable vascular support over a significantly longer period
Iron is an essential trace element for the human body, so the harm of iron-based scaffolds to the human body is far less than that of existing metal stents. The safety of iron-based scaffolds has been proven many times through a large number of experiments.
Iron-Base Scaffolds have been proven to have good biocompatibility through more than 5,000 animal experiments. Compared with permanent stents, iron scaffolds have minimized inflammatory responses or systemic toxic reactions.
IBS is the only iron-based drug-eluting scaffold that can compete with traditional drug-eluting stents. It is a real BRS like DES. We believe that the future iron scaffold will definitely provide doctors with safer and more effective treatment options, bring different blood to the cardiovascular device industry, and make BRS the new mainstream of coronary intervention.
Providing safe choices with technological innovation, the latest information is all in Biotyx
